Quality-of-life improvement with relugolix combination therapy in patients with heavy menstrual bleeding associated with uterine fibroids: results from the liberty phase 3 program.
dc.creator | Al-Hendy, Ayman | |
dc.creator | Stewart, Elizabeth A. | |
dc.creator | Venturella, Roberta | |
dc.creator | Poindexter, Alfred | |
dc.creator | Villarroel Quintana, Claudio | |
dc.creator | Kang, Jennifer | |
dc.creator | Wagman, Rachel B. | |
dc.creator | Hunsche, Elke | |
dc.creator | Lukes, Andrea S. | |
dc.date.accessioned | 2021-05-04T19:20:44Z | |
dc.date.available | 2021-05-04T19:20:44Z | |
dc.date.created | 2021-05-04T19:20:44Z | |
dc.date.issued | 2020 | |
dc.identifier | Fertility and Sterility Volumen: 114 Número: 3 Sep 2020 | |
dc.identifier | 0015-0282 | |
dc.identifier | https://repositorio.uchile.cl/handle/2250/179420 | |
dc.language | en | |
dc.publisher | Elsevier | |
dc.source | Fertility and Sterility | |
dc.title | Quality-of-life improvement with relugolix combination therapy in patients with heavy menstrual bleeding associated with uterine fibroids: results from the liberty phase 3 program. | |
dc.type | Artículo de revista |